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19th CardioVascular Summit: TCTAP 2014supply of PDA from LAD, a large part of the heart was dependent on the LAD. The
operative risk of PCI with retrograde approach by using the LAD as donor artery was
considered high. We got the inotropes, intra-aortic balloon pump (IABP), and extra-
corporeal membranous oxygenator ready in the catheterization laboratory, in order to
provide prompt hemodynamic support when necessary.
A septal perforator with a good collateral channel was identiﬁed by selective contrast
injection through the Corsair microcatheter. Miracle 6 guidewire was brought to the
distal CTO cap via the retrograde route. An intravascular ultrasound over the ante-
grade guidewire conﬁrmed the subintimal position of the retrograde guidewire and the
native vessel size. Reverse controlled antegrade and retrograde subintimal tracking
(CART) technique with a Sprinter Legend 3.0x15mm balloon was performed at the
proximal CTO cap. The retrograde guidewire was able to get across the CTO through
the subintimal track and then reached the guiding catheter. However it was difﬁcult to
manipulate the Corsair microcatheter through the LCx into the guiding catheter. The
Miracle 6 guidewire in the retrograde route was exchanged to a 300cm Fielder FC
guidewire. It was manipulated back into the guiding catheter for externalization.
Instead of working on the guidewire loop for subsequent steps of intervention, we
preferred to minimize the device load in the donor artery. Therefore the Corsair in the
retrograde route was withdrawn to the septal branch, and a Finecross microcatheter
was brought antegradely through the guidewire across the CTO. Through the Fine-
cross, antegrade guidewire into the distal LCx was established, and the devices in the
retrograde system were withdrawn. The activated clotting time was monitored regu-
larly to ensure a therapeutic range.
A thrombus was then noticed over the ostium of LCx (Fig 2, asterisk). Thrombus
aspiration by a 7F Export catheter yielded large amount of red thrombus. Intra-cor-
onary eptiﬁbatide was given, followed by intra-venous infusion. However the
thrombus load rapidly increased and propagated into the left main artery and caused
LCx acute closure. There was also clot embolization into the distal LAD. At that
juncture, the patient developed chest pain and hypotension (blood pressure 60/
35mmHg). Bolus intravenous adrenaline and dopamine infusion were promptly given
and IABP was inserted quickly, in order to prevent further spiral downhill of clinical
condition. The thrombus load decreased after AngioJet thrombectomy. The residual
thrombi in LCx and LAD were squashed by balloon angioplasty with a Sprinter
Legend 2.5x20mm balloon. A Xience V 2.25/18mm stent was positioned across the
CTO. At the LCx and obtuse marginal branch bifurcation just proximal to the CTO,
bifurcation stenting with 2 DES (Xience V 2.5x23mm in LCx, and Xience V
2.25x18mm in obtuse marginal branch) was performed. The ﬁnal angiogram showed
that the antegrade ﬂow across the CTO was established (Fig 3). The patient was able
to wean off inotropic and IABP support in the coronary care unit and was discharged 5
days later.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/CASCase Summary:
In summary, the patient had a left dominant coronary system and he received distal
LCx CTO PCI by left-to-left retrograde approach. LAD, the major feeding artery of
the heart, was use as the route for retrograde intervention. Acute thrombosis ﬁrst
developed at the ostial LCx, which later propagated to involve the left main artery and
LAD. The blood ﬂow to the whole myocardium was jeopardized and hemodynamic
instability was the result. As CTO intervention is complex and is associated with
certain operative risk, a comprehensive risk-beneﬁt assessment, in the context of
clinical and coronary anatomical proﬁles, should be exercised before the decision to
intervene. Under this high-risk proﬁle, interventionalists should be able to identify and
treat any complication promptly, in order to avoid a spiral downhill course.
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[Clinical Information]
Patient initials or identiﬁer number:
K.S. Lee
Relevant clinical history and physical exam:
She had hypertension for 20 years and no other cardiovascular risk factors. She un-
derwent coronary artery bypass graft (CABG, SV to mLAD & SV to OM) at 1994. InE/Chronic Total Occlusions S127
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19th CardioVascular Summit: TCTAP 20142008, she underwent percutaneous coronary intervention (PCI) due to saphenous vein
failure to mLAD and was implanted with endeavor stent (3.0/30mm, medtronic).
Relevant test results prior to catheterization:
ECG showed normal sinus rhythm without ST changes. Cardiac enzymes were
negative. (CK-MB/TnI 1.16/0.028 [CK-MB < 5.00, TnI < 0.78]) Echo showed no
RWMA (EF¼76%). Cardiac CT showed patent SV (aortic root) to LAD graft and
severe stenosis in another SV (aortic root to OM) graft proximal segment and total
occlusion of distal segment.
Relevant catheterization ﬁndings:
Current coronary angiogram showed total occlusion of LAD os and minimla stenosis
of Lt. main and minimal stenosis of LCx and total occlusion of OM and minimal
stenosis of RCA and patent SV (aortic root) to LAD graft and total occlusion of SV
(aortic root) to OM graft.
[Interventional Management]
Procedural step:
I used a 6Fr AL #1 guiding catheter via Lt. radial artery and ﬁelder XT & runthrough
guidewire. The two coronary drug-eluting stent were inserted from SV graft os to
distal lesion. (Resolute integrity 3.0/38mm and 3.0/22mm, Medtronic)
Case Summary:
She had hypertension for 20 years and no other cardiovascular risk factors. She un-
derwent coronary artery bypass graft (CABG, SV to mLAD & SV to OM) at 1994. In
2008, she underwent percutaneous coronary intervention (PCI) due to saphenous vein
failure to mLAD and was implanted with endeavor stent (3.0/30mm, medtronic). ECG
showed normal sinus rhythmwithout ST changes. Cardiac enzymeswere negative. (CK-
MB/TnI 1.16/0.028 [CK-MB<5.00, TnI< 0.78]) Echo showed noRWMA(EF¼76%).
Cardiac CT showed patent SV(aortic root) to LAD graft and severe stenosis in another
SV(aortic root to OM) graft proximal segment and total occlusion of distal segment.
Current coronary angiogram showed total occlusion of LAD os and minimla stenosis of
Lt. main andminimal stenosis of LCx and total occlusion of OMandminimal stenosis of
RCA and patent SV(aortic root) to LAD graft and total occlusion of SV(aortic root) to
OM graft. I used a 6Fr AL #1 guiding catheter via Lt. radial artery and ﬁelder XT &
runthrough guidewire. The two coronary drug-eluting stent were inserted from SV graft
os to distal lesion. (Resolute integrity 3.0/38mm and 3.0/22mm,Medtronic) I used a 6Fr
AL #1 guiding catheter via Lt. radial artery and ﬁelder XT& runthrough guidewire. The
two coronary drug-eluting stent were inserted fromSV graft os to distal lesion. (Resolute
integrity 3.0/38mm and 3.0/22mm, Medtronic)
TCTAP C-099
Achieve a Middle LAD Chronic Total Occlusion with Ipsilateral Double Guide
Catheter
Hsin Ru Li, Sung Shih-Hsien
Taipei Veteran General Hospital, Taiwan
[Clinical Information]
Patient initials or identiﬁer number:
MT Chen
Relevant clinical history and physical exam:
85 y/o male with history of CAD, HTN, exertional syncope one month ago
Relevant test results prior to catheterization:
Coronary artery computer tomography showed middle LAD chronic total occlusion
Relevant catheterization ﬁndings:
CAD with TVD and LAD-P total occlusion with severe calciﬁcation, LCX: patent,
RCA –P to –D: instent patent
[Interventional Management]
Procedural step:
WeengagedLMCAwith EBU4/7GC.One sionGWwas adv anced to LCX-Dunder the
support of Finecross MC. Distal injection showed poor distal collateral. Therefore, we
decided to used FR 4/7 GC to engaged RCA. One sion GWwas advanced to RCA-PDA
under the support of Finecross MC. However, we failed to advance the Finecross MC
through the stent strut. Then, we tried theRVbranch and failed again. Therefore, we tried
the antegrade approach again.We used sion GW under the support of Finecross MC and
we managed to advanced the sion GW into LAD-D. Then, we shift to Corsair MC and
man age to cross the collaterals. Then, we usedOne Pilot 200GWwas advanded to distal
cap andwe try to cross the distal cap but failed. Then, we usedMiracle 6GWandmanage
to cross the lesion. However, false lumen was impressed. Therefore, we used Conquest
pro 12 and placed one runthrough ﬂoopy GW for marker wire in LAD-P. However, we
still failed to advanced to retrograde wire. Then, we used one Conquest 8-20GW and
cross the lesion successfully into LM. During exchange wire, we dislodge the wire and
we recross the lesion again but failed. Then, we used one Fielder FC, Provia 12 GW and
one conquest 8-20 sequentially and ﬁnally cross the lesion. Then, we used another FL
4.5/7GC to engaged LMCA.OneRunthroughﬂoopyGWunder the support of Finecross
MC and exchange into the retrograde Corsair MC in Fl 4.5/7 GC with Rendervous
technique. And we change the runthrough ﬂoopy GW into LAD-D1 antegradely. Then,
we we used one 2.0*20mmBC to inﬂate LM to LAD-Mwith pressure up to 4 atm. Then,
we try to used the IVUS to check the true lumen and failed to advanced to LAD-D1.
Therefore, we used sprinter legend 2.5*20mmBC to inﬂate LM to LAD-Mwith pressure
up to 8 atm. The IVUS then, showed true false true in LAD-M. Then,we used oneWizard
GW to advanced to LAD-D successfully under the support of Crusade MC. But we
cannot pass the 2.0BC into LAD-D. Therefore we used another Runthrough GW and
advanced thewire into LAD-Dunder the support of CrusadeMC.One trek 1.2x6mmBC
was inﬂated in LAD-Mwith pressure up to 14 atm. Then, one Sprinter legend 2.5*15mm
BC was inﬂated in LAD-P to D with pressure up to 14atm. The IVUS showed patent
LCX-Os and D1-Os. Due to post POBA dissection type B, one Promus elementS128 JACC Vol 63/12/Suppl S j A2.5*28mm DES was deployed in LAD-P to D with pressure up to 12 atm under the
support of Guideliner. Another Promus lement 2.75*28mmDESwas deployed in LM to
LAD-P with pressure up to 12 atm. One NC sprinter 3.0*15mm BC was inﬂated instent
with pressure up to 14atm. The ﬁnal result of LAD was fair with TIMI 3 ﬂow.pril 22–25, 2014 j TCTAP Abstracts/CASE/Chronic Total Occlusions
